IFNG and neoplasm: During the course of an immune response, activated T cells release pro-inflammatory cytokines such as IFN-γ that can up-regulate PD-L1 on tumor and host cells.38–40 The increase in PD-L1 expression in MC38 cells after therapy with mIgG1 and mIgG1-N297A (figure 5I) might, therefore, reflect ongoing immune activation with secretion of inflammatory cues in the TME.